Fluvastatin Versus Hepatitis C Virus

Not Applicable

Completed

• Conditions: Hepatitis C

• Registration Number: NCT00441493
• Lead Sponsor: Bader, Ted, M.D.

Brief Summary

This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.

Detailed Description

Four different oral doses of fluvastatin will be used for 14 days and the viral load of hepatitis C will be measured weekly. This has been extended to different doses for 9-12 weeks.

Study Timeline

• Status Verified: 2006-09
• Study Start: 2006-09
• Study First Submitted: 2007-02-27
• Study First Submitted QC: 2007-02-28
• Primary Completion: 2007-03
• Study First Posted: 2007-03-01
• Study Completion: 2007-09
• Last Update Submitted: 2012-07-26
• Last Update Posted: 2012-07-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• HCV RNA positive

Exclusion Criteria

• Testing positive for alcohol or marijuana

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Viral Load Reduction, Liver test changes

Trial Locations

Locations (1)

VA Medical Center; 🇺🇸 Oklahoma City, Oklahoma, United States